Description
EXPRESS REPORT: 5 PHARMACY ORDERS 442A60035,442A60044,554A60703,554A60715,554A60726
Base award description: EXPRESS REPORT: 4 PHARMACY ORDERS 436A60004,442A60001,442A60002,554A60571
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-02+$21,294= $21,294
- Mod P000022015-11-02+$27,549= $48,842
- Mod P000032015-12-09+$29,634= $78,476
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-02 | +$21,294 | $21,294 | EXPRESS REPORT: 4 PHARMACY ORDERS 436A60004,442A60001,442A60002,554A60571 |
| Mod P00002· FUNDING ONLY ACTION | 2015-11-02 | +$27,549 | $48,842 | EXPRESS REPORT: 5 PHARMACY ORDERS 436A60017,442A60014,442A60015,554A60628,554A60657 |
| Mod P00003· FUNDING ONLY ACTION | 2015-12-09 | +$29,634 | $78,476 | EXPRESS REPORT: 5 PHARMACY ORDERS 442A60035,442A60044,554A60703,554A60715,554A60726 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EP32BZ8XN3A2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26123P0628 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $14,221 | FY2023 |
| 36C26123P0590 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C26123P0479 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26123P0366 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26123P0086 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26122P1803 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2022 |
Other recipients under 6505 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25916E2832 | GRIFOLS USA LLC | 259-NETWORK CONTRACT OFFICE 19 | $16,949 | FY2016 |
| VA25916P2108 | BAXALTA US INC. | 259-NETWORK CONTRACT OFFICE 19 | $6,212 | FY2016 |
| VA25916E2677 | GRIFOLS THERAPEUTICS LLC | 259-NETWORK CONTRACT OFFICE 19 | $12,066 | FY2016 |
| VA25916P1705 | MCKESSON CORPORATION | 259-NETWORK CONTRACT OFFICE 19 | $11,043 | FY2016 |
| VA25916P1805 | BIOLOGICS, INC. | 259-NETWORK CONTRACT OFFICE 19 | $10,442 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25916E0720_3600_-NONE-_-NONE- · retrieved 2026-09-26.